All Updates

All Updates

icon
Filter
Funding
nference raises USD 60 million in Series C funding
AI Drug Discovery
Dec 15, 2020
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Dec 15, 2020

nference raises USD 60 million in Series C funding

Funding

  • Massachusetts-based nference has raised USD 60 million in Series C funding led by Matrix Capital Management, with participation from Matrix Partners, Mayo Clinic Ventures, and NTTVC. 

  • nference intends to use the proceeds to advance the development of software and learning models on its nferX software platform, enabling novel diagnostics and therapeutics. 

  • Founded in 2013, nference operates a biomedical knowledge synthesis platform that captures and analyzes health data, including unstructured information to help researchers in drug discovery. Its AI-powered platform uses neural networks (shallow and deep learning models) for the automatic extraction of insights from clinical notes, scientific literature, pathology images, ECG waveforms, and genomic sequences.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.